Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;52(5):1506-1512.
doi: 10.55730/1300-0144.5490. Epub 2022 Oct 19.

Magnetic resonance imaging findings in COVID-19-related anosmia

Affiliations

Magnetic resonance imaging findings in COVID-19-related anosmia

Hüseyin Çetin et al. Turk J Med Sci. 2022 Oct.

Abstract

Background: The coronavirus disease 2019 (COVID-19) mostly manifests with fever, shortness of breath, and cough, has also been found to cause some neurological symptoms, such as anosmia and ageusia. The aim of the study was to present the magnetic resonance imaging (MRI) findings of patients with anosmia-hyposmia symptoms and to discuss potential mechanisms in light of these findings.

Methods: Of the 2412 patients diagnosed with COVID-19-related pneumonia (RT-PCR at least once + clinically confirmed) between March and December 2020, 15 patients underwent olfactory MRI to investigate the cause of ongoing anosmia/ hyposmia symptoms were included in the study.

Results: Eleven (73.3%) patients were female and four (26.7%) were male. A total of eight patients (53.3%) showed thickening in the olfactory cleft region, where the olfactory epithelium is located. In nine patients (60%), enhancement was observed in the olfactory cleft region. Diffusion-weighted imaging showed restricted diffusion in three patients (20%) (corpus callosum splenium in one patient, thalamus mediodorsal nucleus in one patient, and mesencephalon in one patient).

Discussion: This study revealed that there is a relationship between anosmia and MRI findings. Larger studies can enlighten the pathophysiological mechanism and shed light on both diagnosis and new treatments.

Keywords: COVID-19; anosmia; magnetic resonance imaging.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Coronal pre- (a) and postcontrast (b) T1-weighted image showing thickening and enhancement in the bilateral olfactory cleft and mucosa.
Figure 2
Figure 2
Coronal pre- (a) and postcontrast (b) T1-weighted image showing thickening and enhancement in the right olfactory cleft and mucosa.
Figure 3
Figure 3
Axial diffusion-weighted image (a) (b = 1000) and the apparent diffusion coefficient (ADC) map (b) showing a diffusion-restricted lesion in the splenium of the corpus callosum (arrow).
Figure 4
Figure 4
The control images of the same patient, axial diffusion-weighted image (a) (b = 1000) and the apparent diffusion coefficient (ADC) map (b), shows that the lesions disappeared.

Similar articles

Cited by

References

    1. Ates OF, Taydas O, Dheir H. Thorax magnetic resonance imaging findings in patients with coronavirus disease (covid-19) Academic Radiology. 2020;27(10):1373–1378. doi: 10.1016/j.acra.2020.08.009. - DOI - PMC - PubMed
    1. Lüers JC, Klußmann JP, Guntinas-Lichius O. [the covid-19 pandemic and otolaryngology: What it comes down to?]. Laryngo- rhino- otologie. 2020;99(5):287–291. doi: 10.1055/a-1095-2344. - DOI - PubMed
    1. Bagheri SH, Asghari A, Farhadi M, Shamshiri AR, Kabir A, et al. Coincidence of covid-19 epidemic and olfactory dysfunction outbreak in Iran. Medical Journal of the Islamic Republic of Iran. 2020;34:62. doi: 10.34171/mjiri.34.62. - DOI - PMC - PubMed
    1. Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, et al. Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: A cross-sectional study. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2020;71(15):889–890. doi: 10.1093/cid/ciaa330. - DOI - PMC - PubMed
    1. Moein ST, Hashemian SM, Mansourafshar B, Khorram-Tousi A, Tabarsi P, et al. Smell dysfunction: A biomarker for covid-19. International Forum of Allergy & Rhinology. 2020;10(8):944–950. doi: 10.1002/alr.22587. - DOI - PMC - PubMed